Institutional & Family Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $141K | Buy |
255
+85
| +50% | +$47K | 0.02% | 164 |
|
|
2024
Q1 | $98.8K | Sell |
170
-1
| -0.6% | -$581 | 0.02% | 184 |
|
|
2023
Q4 | $90.8K | Buy |
171
+27
| +19% | +$14.3K | 0.01% | 197 |
|
|
2023
Q3 | $72.9K | Buy |
144
+7
| +5% | +$3.54K | 0.01% | 198 |
|
|
2023
Q2 | $71.5K | Buy |
137
+1
| +0.7% | +$522 | 0.01% | 204 |
|
|
2023
Q1 | $78.4K | Sell |
136
-14
| -9% | -$8.07K | 0.01% | 189 |
|
|
2022
Q4 | $82.6K | Sell |
150
-20
| -12% | -$11K | 0.01% | 185 |
|
|
2022
Q3 | $86K | Buy |
170
+8
| +5% | +$4.05K | 0.02% | 180 |
|
|
2022
Q2 | $88K | Sell |
162
-19
| -10% | -$10.3K | 0.02% | 181 |
|
|
2022
Q1 | $107K | Buy |
181
+7
| +4% | +$4.14K | 0.02% | 184 |
|
|
2021
Q4 | $116K | Sell |
174
-86
| -33% | -$57.3K | 0.02% | 190 |
|
|
2021
Q3 | $149K | Buy |
260
+46
| +21% | +$26.4K | 0.02% | 203 |
|
|
2021
Q2 | $108K | Buy |
214
+4
| +2% | +$2.02K | 0.02% | 230 |
|
|
2021
Q1 | $96K | Sell |
210
-153
| -42% | -$69.9K | 0.02% | 274 |
|
|
2020
Q4 | $169K | Sell |
363
-8
| -2% | -$3.73K | 0.04% | 197 |
|
|
2020
Q3 | $164K | Buy |
371
+198
| +114% | +$87.5K | 0.04% | 187 |
|
|
2020
Q2 | $63K | Buy |
173
+6
| +4% | +$2.19K | 0.01% | 285 |
|
|
2020
Q1 | $47K | Sell |
167
-5
| -3% | -$1.41K | 0.01% | 282 |
|
|
2019
Q4 | $56K | Sell |
172
-20
| -10% | -$6.51K | 0.01% | 304 |
|
|
2019
Q3 | $56K | Sell |
192
-2
| -1% | -$583 | 0.01% | 282 |
|
|
2019
Q2 | $57K | Sell |
194
-4
| -2% | -$1.18K | 0.01% | 298 |
|
|
2019
Q1 | $54K | Hold |
198
| – | – | 0.01% | 317 |
|
|
2018
Q4 | $44K | Sell |
198
-6
| -3% | -$1.33K | 0.01% | 336 |
|
|
2018
Q3 | $50K | Sell |
204
-2
| -1% | -$490 | 0.01% | 351 |
|
|
2018
Q2 | $43K | Hold |
206
| – | – | 0.01% | 360 |
|
|
2018
Q1 | $43K | Buy |
+206
| New | +$43K | 0.01% | 343 |
|